182 related articles for article (PubMed ID: 8746621)
1. An open study of mupirocin in Libyan patients with skin infections.
El Ferghani N
J Int Med Res; 1995; 23(6):508-17. PubMed ID: 8746621
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
Gisby J; Bryant J
Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P
Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167
[TBL] [Abstract][Full Text] [Related]
4. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial.
Canpolat F; Erkoçoğlu M; Tezer H; Kocabaş CN; Kandi B
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1989-93. PubMed ID: 23242727
[TBL] [Abstract][Full Text] [Related]
5. Pitted keratolysis: successful management with mupirocin 2% ointment monotherapy.
Greywal T; Cohen PR
Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437161
[TBL] [Abstract][Full Text] [Related]
6. [A trial of the use of mupirocin in the nasal carriage of Staphylococcus aureus in medical personnel].
Dmitrieva NV; Solodovnik FI; Petukhova IN
Antibiot Khimioter; 2000; 45(3):35-8. PubMed ID: 10768065
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial.
Bork K; Brauers J; Kresken M
Br J Clin Pract; 1989 Aug; 43(8):284-8. PubMed ID: 2516463
[TBL] [Abstract][Full Text] [Related]
8. [Mupirocin: prophylaxis of hospital-acquired infections due to Staphylococcus aureus and sanitation of hospital environment].
Mitrokhin SD
Antibiot Khimioter; 2003; 48(9):13-9. PubMed ID: 15002175
[TBL] [Abstract][Full Text] [Related]
9. Anti-biofilm properties of a mupirocin spray formulation against Escherichia coli wound infections.
Bakkiyaraj D; Sritharadol R; Padmavathi AR; Nakpheng T; Srichana T
Biofouling; 2017 Aug; 33(7):591-600. PubMed ID: 28686044
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.
Afset JE; Maeland JA
Scand J Infect Dis; 2003; 35(2):84-9. PubMed ID: 12693555
[TBL] [Abstract][Full Text] [Related]
11. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.
Scangarella-Oman NE; Shawar RM; Bouchillon S; Hoban D
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):269-79. PubMed ID: 19344241
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment.
Sesso R; Barbosa D; Leme IL; Sader H; Canziani ME; Manfredi S; Draibe S; Pignatari AC
J Am Soc Nephrol; 1998 Jun; 9(6):1085-92. PubMed ID: 9621293
[TBL] [Abstract][Full Text] [Related]
13. Dermacase. Perianal streptococcal dermatitis.
Adams SP
Can Fam Physician; 1999 Sep; 45():2059, 2066. PubMed ID: 10509216
[No Abstract] [Full Text] [Related]
14. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains.
Semret M; Miller MA
Infect Control Hosp Epidemiol; 2001 Sep; 22(9):578-80. PubMed ID: 11732789
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema.
Rist T; Parish LC; Capin LR; Sulica V; Bushnell WD; Cupo MA
Clin Exp Dermatol; 2002 Jan; 27(1):14-20. PubMed ID: 11952661
[TBL] [Abstract][Full Text] [Related]
16. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of mupirocin calcium ointment in the treatment of experimental wound infections caused by methicillin-resistant strains of Staphylococcus aureus.
Beale AS; Gisby J; Sutherland R
J Chemother; 1989 Jul; 1(4 Suppl):397-8. PubMed ID: 16312457
[No Abstract] [Full Text] [Related]
18. Use of the surgical wound infection model to determine the efficacious dosing regimen of retapamulin, a novel topical antibiotic.
Rittenhouse S; Singley C; Hoover J; Page R; Payne D
Antimicrob Agents Chemother; 2006 Nov; 50(11):3886-8. PubMed ID: 17065626
[TBL] [Abstract][Full Text] [Related]
19. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.
Ellis MW; Griffith ME; Dooley DP; McLean JC; Jorgensen JH; Patterson JE; Davis KA; Hawley JS; Regules JA; Rivard RG; Gray PJ; Ceremuga JM; Dejoseph MA; Hospenthal DR
Antimicrob Agents Chemother; 2007 Oct; 51(10):3591-8. PubMed ID: 17682105
[TBL] [Abstract][Full Text] [Related]
20. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections.
Odom RB
Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
